This multi-receptor approach may help reduce hunger, increase feelings of fullness, and support gradual, sustainable weight loss as part of a comprehensive weight management program
With FDA enforcement deadlines approaching, compounded versions of semaglutide and tirzepatide are being phased out
Semaglutide reduces the risk of heart disease by improving cardiovascular outcomes and lowering the incidence of major cardiac events
Lumps may indicate lipohypertrophy from repeated injections in the same area
Request a comprehensive panel from your provider: TSH and free T4 (thyroid), fasting glucose, fasting insulin, HbA1c, and cortisol if symptoms warrant it
Many women report improved mental clarity, reduced food noise, and a healthier relationship with eating when dosing is tailored to their physiology rather than driven by scale goals